Stay updated on PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial

Sign up to get notified when there's something new on the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the record history and the previous revision v3.6.6 was removed, updating the version history reflected on the page.
    Difference
    0.1%
    Check dated 2026-09-19T14:31:36.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    A new revision entry (v3.6.6) has been added to the study's history. This updates the record from the previous version (v3.6.5).
    Difference
    0.1%
    Check dated 2026-08-29T14:22:28.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    Record History shows Revision: v3.6.5, replacing v3.6.4. This reflects a minor platform release update to the history page rather than any substantive changes to the trial information.
    Difference
    0.1%
    Check dated 2026-08-08T13:06:39.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    The Study Record Versions history now shows Revision: v3.6.4, indicating a new platform release for the page. This update is a metadata version change and does not alter the trial data or visible content.
    Difference
    0.1%
    Check dated 2026-07-25T13:31:52.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    A new revision entry, v3.6.3, was added to the study's record history, and the previous revision, v3.6.2, was removed from the list.
    Difference
    0.1%
    Check dated 2026-07-04T14:43:14.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    The study record history now includes a new revision entry for v3.6.2, following the previous v3.6.0 entry, signaling an administrative update to the record.
    Difference
    0.1%
    Check dated 2026-06-27T13:45:44.000Z thumbnail image

Stay in the know with updates to PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-L1+ NSCLC Camrelizumab + Famitinib Clinical Trial page.